Polen Capital acquired 1.2M Idexx Laboratories shares worth $755M. That's 2.21% of their equity portfolio (20th largest holding). The investor owns 1.49% of the outstanding Idexx Laboratories stock. The stake costed the investor $572M, netting the investor a gain of 32% so far.
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downl...
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” third-quarter investor letter. A copy of...
Brinker Capital Investments LLC lessened its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Rating) by 3.4% during the 4th quarter, Holdin...
LGT Capital Partners LTD. trimmed its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 3.0% in the third quarter, according to its most recent...